Lucía González Cortijo
Lucía González Cortijo
JEFE/A DE SERVICIO
Oncología Médicaes/especialidades/oncologia-medica
Ver más especialistas en
Madridmadrid
es/cuadro-medico/oncologo
Datos destacados
- Última publicación:Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
Datos del profesional
Hospital Universitario Quirónsalud Madrid
JEFE/A DE SERVICIO
Febrero 2009
Olympia Centro Médico Pozuelo
JEFE/A DE SERVICIO
Septiembre 2025
Hospital Universitario Quirónsalud Madrid
Facultativo/a esp.
Febrero 2009
MD Anderson International España
Facultativo/a esp.
Febrero 2002
Estudio
Licenciada en Medicina y Cirugía
universidad, Universidad Autónoma de Madrid
1996
Doctorado
Universidad Autónoma de Madrid
2018
Formación Sanitaria Especializada
Especialidad en Oncología Médica
hospital
Idioma
Preliminary in English
Idioma
Certificate of Proficiency in English
Idioma
Endorsement to Certificate of Proficiency in English: Literature
Idioma
Endorsement to Certificate of Proficiency in English: Translation from English into Spanish
Idioma
First Certificate in English
Otra titulación
PADIS (Programa de Alta Dirección en Instituciones Sanitarias)
escuela
Otra titulación
Máster de Oncología Molecular
instituto
Otra titulación
Career Advancement and Leadership for Women in Healthcare
universidad
Oncología Médica
Universidad Europea de Madrid
Estudios fases II-III en cáncer de mama y ginecológico
Corre en Rosa
2015
Fundación La Vida en Rosa
2017
Línea de investigación traslacional sobre ejercicio y cáncer de mama
Cátedra de Ejercicio de la Universidad Europea de Madrid
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
Journal Article
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Published Erratum
Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer.
Journal Article
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Journal Article
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
Journal Article, Review
MRI guided ROLL/SNOLL in breast cancer patients treated with neoadjuvant chemotherapy.
Journal Article
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Journal Article
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.
Journal Article
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.
Case Reports, Letter
Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Journal Article
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Journal Article
Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
Journal Article
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Journal Article
Inglés
Bilingüe
